Search research articles
Contact Us
Filters
Showing results (481-490 of 516) with videos related to
Page
of 52
Sort By:
British Journal of Haematology
|
January 14, 2010
Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy
Herbert Pichler, Anja Möricke, Georg Mann, et al.
Klinische Padiatrie
|
June 4, 2004
Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor
H Reinhard, O Semler, D Bürger, et al.
Nature Medicine
|
August 30, 2008
An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice
Milena Traykova-Brauch, Kai Schönig, Oliver Greiner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2021
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies
Mark W Skinner, Claude Négrier, Ido Paz-Priel, et al.
The New England Journal of Medicine
|
August 30, 2018
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
Johnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, et al.
The Lancet. Child & Adolescent Health
|
June 5, 2020
39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial
Christa Koenig, Nicole Bodmer, Philipp K A Agyeman, et al.
Leukemia
|
December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A Möricke, M Zimmermann, A Reiter, et al.
Nature Communications
|
September 16, 2020
Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity
Gabriele Manzella, Leonie D Schreck, Willemijn B Breunis, et al.
Haematologica
|
April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Janina Heilmann, Simon Vieth, Anja Möricke, et al.
Frontiers in Oncology
|
May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
Sebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Page
of 52
Search research articles
Search
Showing results (481-490 of 516) with videos related to
Sort By:
Page
of 52
British Journal of Haematology
|
January 14, 2010
Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy
Herbert Pichler, Anja Möricke, Georg Mann, et al.
Klinische Padiatrie
|
June 4, 2004
Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor
H Reinhard, O Semler, D Bürger, et al.
Nature Medicine
|
August 30, 2008
An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice
Milena Traykova-Brauch, Kai Schönig, Oliver Greiner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2021
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies
Mark W Skinner, Claude Négrier, Ido Paz-Priel, et al.
The New England Journal of Medicine
|
August 30, 2018
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
Johnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, et al.
The Lancet. Child & Adolescent Health
|
June 5, 2020
39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial
Christa Koenig, Nicole Bodmer, Philipp K A Agyeman, et al.
Leukemia
|
December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A Möricke, M Zimmermann, A Reiter, et al.
Nature Communications
|
September 16, 2020
Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity
Gabriele Manzella, Leonie D Schreck, Willemijn B Breunis, et al.
Haematologica
|
April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Janina Heilmann, Simon Vieth, Anja Möricke, et al.
Frontiers in Oncology
|
May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
Sebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Page
of 52